Last update 23 Jan 2025

Chemical Diversity Research Institute CJSC

Subsidiary Company|
1998|
Russia
|
www.iihr.ru

Overview

Tags

Respiratory Diseases
Infectious Diseases
Cardiovascular Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Infectious Diseases2
Top 5 Drug TypeCount
Small molecule drug3
Top 5 TargetCount
DprE1(FAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase)1
ARG2(arginase 2)1
CEN(cap-dependent endonuclease)1

Related

3
Drugs associated with Chemical Diversity Research Institute CJSC
Macozinone
Target
DprE1
Mechanism
DprE1 inhibitors
Active Org.
Chemical Diversity Research Institute CJSC [+2]
Originator Org.
École Polytechnique Fédérale de LausanneÉcole Polytechnique Fédérale de Lausanne
Active Indication
Pulmonary Tuberculosis [+1]
Inactive Indication-
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
AV5116
Target
CEN
Mechanism
CEN inhibitors
Active Org.
Moscow Institute of Steel & AlloysMoscow Institute of Steel & Alloys [+1]
Originator Org.
Moscow Institute of Steel & AlloysMoscow Institute of Steel & Alloys [+1]
Active Indication
Influenza, Human
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
ZB-49-0010
Target
ARG2
Mechanism
ARG2 inhibitors
Active Org.
Chemical Diversity Research Institute CJSC
Originator Org.
Chemical Diversity Research Institute CJSC
Active Indication
Atherosclerosis [+1]
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Chemical Diversity Research Institute CJSC
NCT04434248
/ Unknown statusPhase 2/3
An Adaptive, Multicenter, Randomized, Open-label, Comparative Clinical Study to Assess Efficacy and Safety of Favipiravir in Hospitalized Patients With COVID-19
100 Clinical Results associated with Chemical Diversity Research Institute CJSC
Login to view more data
0 Patents (Medical) associated with Chemical Diversity Research Institute CJSC
Login to view more data
100 Deals associated with Chemical Diversity Research Institute CJSC
Login to view more data
100 Translational Medicine associated with Chemical Diversity Research Institute CJSC
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 18 Feb 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
3
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Macozinone
 ( DprE1 )		Tuberculosis
More
Preclinical
AV5116
 ( CEN )		Influenza, Human
More
Preclinical
ZB-49-0010
 ( ARG2 )		Atherosclerosis
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free